KYKOF - Ardelyx gains as Japan approves kidney disease therapy
2023-09-25 07:21:20 ET
More on Ardelyx
- Seeking Alpha’s Quant Rating on Ardelyx
- Historical earnings data for Ardelyx
- Financial information for Ardelyx
- Ardelyx: Niche Products For Competitive Markets
- Cantor upgrades Ardelyx to overweight ahead of FDA decision on renal drug
For further details see:
Ardelyx gains as Japan approves kidney disease therapy